Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden
· Delayed Price · Currency is SEK 6.05
+0.08 (1.34%)
Jan 17, 2025, 5:24 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.13 billion as of January 21, 2025. Its market cap has increased by 26.86% in one year.
Market Cap
2.13B
Enterprise Value
2.11B
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.05
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.13B, an increase of 845.65%. That is a compound annual growth rate of 17.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.61B |
| Getinge AB | 52.49B |
| Sectra AB | 48.16B |
| Camurus AB | 33.40B |
| Medicover AB | 30.10B |
| Vitrolife AB | 28.16B |
| Bonesupport Holding AB | 24.57B |
| Elekta AB | 24.22B |